04/28/2026
Dr. Patrick C. Hines will chair the Investigational New Drug, Device, and Therapeutics Symposium — bringing together leading pharmaceutical and industry experts to spotlight the most promising therapies in the SCD development pipeline.
Dr. Hines is a physician-scientist whose work has been instrumental in translating basic science discoveries into diagnostic tools that predict clinical outcomes and monitor patient response to emerging therapies.
Attendees of this session will be equipped to:
- Describe the current landscape of investigational drugs and biologics in development for SCD and their mechanisms of action
- Compare emerging strategies — including gene therapies, disease-modifying agents, and targeted biologics — across clinical rationale, trial design, and anticipated impact
- Evaluate the role of translational biomarkers and functional assays in measuring therapeutic response and disease heterogeneity
- Analyze key challenges in the SCD clinical development pathway, from regulatory considerations to patient and endpoint selection
- Discuss strategies to accelerate the translation of investigational therapies into practice while ensuring equitable access for those living with SCD
We invite you to join us in Fort Lauderdale for this session.
Register Here: https://fscdr2026.eventscribe.net/